CompoAtlas

Dr. Reckeweg R61

Natural health product licensed in Canada

Other names
Dr. Reckeweg R61 Lumbagin
Licence holder
Bio Lonreco Inc.
NPN or DIN-HM
80031915
Status
Active licence
Licence date
3 May 2012
Revision date
Not provided
Form
Onguent
Route of administration
Topique
Application type
Homéopathique

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Berberis vulgaris

Source : Écorce séchée de parties aériennes et souterraines

Potency : 0.1 g of MT dilution

Not specified
Oleum gaultheriae

Source : Essential oil from fresh leaves

Potency : 3.5 g of D4 dilution

4 D
Rhus toxicodendron

Source : Jeunes pousses fraiches pas encore lignifiées, avec feuilles

Potency : 0.1 g of D12 dilution

12 D

Non-medicinal ingredients

Alcool cétostéarylique, Huile de lavande, Alcool de lanoline, Pétrolatum

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 12 yearsNot specifiedminimum: 2 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Homeopathic Medicine.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80031915

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line